PT Kalbio Global Medika is one of three 2017 Facility of the Year® Honorable Mention winners for their Biotechnology Facility in Jakarta, Indonesia.Projects selected for recognition with an Honorable Mention Award are typically projects that utilize new technology or are located in a challenging region of the world. These projects do not win for a specific category but are clearly successful projects that overcame significant challenges in planning, execution, and delivery, and deserve recognition for their achievements.
PT Kalbio Global Medika, located in Indonesia, manufactures biological and biotech products for the Indonesian and SE Asia markets. The company vision and long-term goals is to expand outside their region. The 40,000-sq. ft. site, built on a plot in the Cikarang industrial park on the East side of Jakarta was formed in part due to a call from the Indonesian government to encourage in-country biologics and biomanufacturing manufacturing. PT Kalbio Global Medika had a young, ambitious and dedicated team, with an average age of only 24. This team, maintained their expenses to 96% of the initial budget after having completed construction, equipment fit out, and validation with 4% to spare.
Having a forward-thinking team eager to take work as a team to achieve great things aided them in not only meeting but exceeding their goals. A point of pride is PT Kalbio Global Medika’s implementation of a full Quality Management System that is compliant to the PIC/S guidelines and is one of the first in SE Asia that meets the “Risk Based Approach” to manufacturing. PT Kalbio Global Medika also adopted a “green” mentality in their design and operation in an effort to reduce their environmental impact. They used novel methods for decontamination and sanitation as well as solar power to be more energy efficient. ISPE congratulates the PT Kalbio Global Medika team for their achievements and their FOYA award-winning entry. Learn more about the 2017 FOYA Honorable Mention winner.Kalbio_Sterility_Isolator_1.jpg
Has your company recently designed, built, or renovated a state-of-the-art pharmaceutical or biotechnology facility that is best in its class? Submit an entry into the 2018 ISPE Facility of the Year Awards (FOYA) Program, and your facility may win a coveted Facility of the Year Award.
Biocon Biologics is one of the 2021 Facility of the Year Awards Winner for the 2021 Facility of the Year Honorable Mention Award for their Biocon Biologics Manufacturing (B3) project in Bangalore, India.
ICH Q10 outlines three objectives: achieve product realization, establish and maintain a state of control, and facilitate continual improvement. Embracing these objectives can be best achieved using the dual enablers, Knowledge Management (KM) and Quality Risk Management (QRM). The pharmaceutical...
Featured in this edition of the Pharmaceutical Engineering® Online Reading Roundup are highlights from the magazine ten years ago in 2011. Revisit articles on single-use in biomanufacturing, contained dust collection systems, manufacturing execution systems, and more.